https://www.prnewswire.com/news-releases/stimlabs-announces-enrollment-of-first-patient-in-trial-investigating-the-efficacy-of-full-thickness-human-placental-graft-revita-in-diabetic-foot-ulcers-300787844.html
StimLabs Announces Enrollment of First Patient in Trial Investigating the Efficacy of...
/PRNewswire/ -- StimLabs, a leader in regenerative technologies and products that are revolutionizing patient care, today announced that the first patient...
first patientannouncesenrollment